CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Up 600.7% in February

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a large increase in short interest in February. As of February 27th, there was short interest totaling 44,566 shares, an increase of 600.7% from the February 12th total of 6,360 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 4,555,419 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 4,555,419 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

CV Sciences Price Performance

CVSI opened at $0.05 on Thursday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.21. CV Sciences has a 12 month low of $0.02 and a 12 month high of $0.10. The business has a 50 day simple moving average of $0.05 and a 200-day simple moving average of $0.04.

CV Sciences Company Profile

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.